October sure was a busy month for news in the drug channel. It began in earnest on Oct. 1, the day CVS’ new president officially began his new job. Before the month was over, CVS’ chief merchant left to become president of Family Dollar, and his responsibilities would be carved up between three key executives.
In September, the Generic Pharmaceutical Association announced the appointment of Ralph Neas — former president and CEO of the National Coalition on Health Care — as its new president and CEO, replacing Kathleen Jaeger, who stepped down as president and CEO of the organization in May 2010.
Help Remedies, a New York-based creator of "minimalist" over-the-counter medicine, on Tuesday announced national distribution for its line of single-ingredient nonprescription remedies through Walgreens.
Unilever’s Gina Boswell, who was recently appointed EVP personal care for North America, has been selected as a 2011 Achiever of the Year, one of the highest awards bestowed in the beauty industry, by nonprofit Cosmetic Executive Women.
The news that Shoppers Drug Mart has appointed former McKesson Canada executive Domenic Pilla as its new president and CEO not only is significant news in its own right, but also is important as Pilla will inherit a chain that is wrestling with the impact of drug reforms in several provinces and faces its share of competitive challenges.
Family Dollar is on a mission to increase traffic to its stores — of which it intends to build twice as many in fiscal 2012 as it did in fiscal 2011 — and grow its market basket. That has meant a growing emphasis on what it considers its consumables business, a substantial portion of which is constituted by health and beauty aids.
Representatives from leading health systems came together to discuss evolving efforts in coordinated patient care at the first Walgreens Health Systems Executive Client Forum, Walgreens stated Thursday.
Navarro Discount Pharmacy, a Hispanic-owned pharmacy chain and an MBF Healthcare portfolio company, has expanded its management team by naming Luis Mier as CFO and promoting Manuel Leon to VP wholesale and OTC programs.